Indivior PLC
Indivior PLC (INVVY) Revenue
Annual & quarterly revenue history · segment & region breakdown
INVVY · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsIndivior PLC trailing twelve-month (TTM) revenue is $1.00B, an increase of 13.91% year-over-year from $0.90B in FY2022.
Revenue trend
2022 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-12-31 | $0.90B | +$0.11B | +13.91% |
| 2021-12-31 | $0.79B | +$0.14B | +22.26% |
| 2020-12-31 | $0.65B | -$0.14B | -17.58% |
| 2019-12-31 | $0.79B | — | — |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare INVVY revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Indivior PLC receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Indivior PLC reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Indivior PLC's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
INVVY revenue · 4 questionsINVVY's trailing twelve-month (TTM) revenue is $1.00B. That is an increase of 13.91% year-over-year from $0.90B in FY2022.
▸ Source: FMP · Indivior PLC SEC filings · GAAP · Indivior PLC SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026